About PredxBio
PredxBio is a private company based in Pittsburgh, Pennsylvania. It has reported $1,999,578 raised in five offerings on Form D since September 2018. Its chief executive is B. Dusty Majumdar.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2023 | Aug 17, 2023 | $601,321of $4.0M target | 11 | $54,666 | EquityRule 506(b) | Form D ↗ |
| Jan 27, 2021 | Feb 4, 2021 | $260,000of $350K target | 4 | $65,000 | EquityRule 506(b) | Form D ↗ |
| Jul 31, 2020 | Aug 14, 2020 | $463,257fully sold | 7 | $66,180 | EquityRule 506(b) | Form D ↗ |
| Jul 26, 2019 | Aug 6, 2019 | $275,000of $400K target | 4 | $68,750 | EquityRule 506(b) | Form D ↗ |
| Aug 24, 2018 | Sep 6, 2018 | $400,000fully sold | 6 | $66,667 | Equity, DebtRule 506(b) | Form D ↗ |
| Total, five offerings | $1,999,578 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on PredxBio's Form D filed Aug 17, 2023.
SM
Stanley Marks
Director
SC
Srinivas Chennubhotla
Executive officer and director
WN
William Newlin
Director
BM
B. Dusty Majumdar
CEO and director
DT
D. Lansing Taylor
Director
Earlier filings also listed S. Chakra Chennubhotla (ceo and director, last listed Feb 2021).